Autolus Therapeutics Analyst Price Targets

Autolus Therapeutics PLC

AUTLNASDAQ

Trade with Public

$1.59

-0.01-0.63%

Ult. Agg.: Oct 19, 7:43 PM

$1.59

-0.01-0.63%

Panoramica Notizie Previsioni utili EventiObiettivi di prezzoDati finanziari Sentiment Azionariato Confronta Opzioni Rapporto azionario

Autolus Therapeutics Analyst Price Targets

Wall Street analyst price targets and consensus rating for Autolus Therapeutics (AUTL).

Price Target Range — 11 Quarters

Analyst Consensus — 8 Analysts

8Buy

Consensus RatingBuy# Analysts8Avg. Consensus PT$9Upside to Avg. PT+474.8%

Rating Trend — Last 9 Months

Recent Analyst Actions

Visualizza tutte le valutazioni →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 3, 2026	HC Wainwright & Co.	Emily Bodnar	Maintained	Buy	$10
May 14, 2026	HC Wainwright & Co.	Emily Bodnar	PT Raise	Buy	$9→$10
Apr 9, 2026	Needham	Gil Blum	Maintained	Buy	$10
Mar 31, 2026	Mizuho	Salim Syed	PT Cut	Outperform	$12→$10
Mar 27, 2026	Needham	Gil Blum	Maintained	Buy	$10
Feb 17, 2026	HC Wainwright & Co.	Emily Bodnar	Initiate	Buy	$9
Jan 12, 2026	Needham	Gil Blum	PT Cut	Buy	$11→$10
Dec 29, 2025	Needham	Gil Blum	PT Raise	Buy	$10→$11
Dec 12, 2025	Needham	Gil Blum	Maintained	Buy	$10
Nov 3, 2025	Needham	Gil Blum	Maintained	Buy	$10
Oct 20, 2025	Needham	Gil Blum	Maintained	Buy	$10
Aug 13, 2025	Wells Fargo	Yanan Zhu	PT Cut	Overweight	$6→$5
Jul 21, 2025	Needham	Gil Blum	Maintained	Buy	$10
Jun 12, 2025	Needham	Gil Blum	Maintained	Buy	$10
Apr 10, 2025	Needham	Gil Blum	Maintained	Buy	$10
Apr 1, 2025	Truist Securities	Asthika Goonewardene	PT Cut	Buy	$11→$10
Mar 21, 2025	Wells Fargo	Yanan Zhu	PT Cut	Overweight	$8→$6
Jan 13, 2025	Needham	Gil Blum	Maintained	Buy	$10
Dec 9, 2024	Needham	Gil Blum	Maintained	Buy	$10
Dec 5, 2024	Needham	Gil Blum	Maintained	Buy	$10

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
HC Wainwright & Co. Reiterates Buy on Autolus Therapeutics, Maintains $10 Price Target

HC Wainwright & Co. analyst Emily Bodnar reiterates Autolus Therapeutics (NASDAQ:AUTL) with a Buy and maintains $10 price target.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on Autolus Therapeutics, Raises Price Target to $10

HC Wainwright & Co. analyst Emily Bodnar maintains Autolus Therapeutics (NASDAQ:AUTL) with a Buy and raises the price target from $9 to $10.

Benzinga Newsdesk

PRO
Needham Reiterates Buy on Autolus Therapeutics, Maintains $10 Price Target

Needham analyst Gil Blum reiterates Autolus Therapeutics (NASDAQ:AUTL) with a Buy and maintains $10 price target.

Benzinga Newsdesk

PRO
Mizuho Maintains Outperform on Autolus Therapeutics, Lowers Price Target to $10

Mizuho analyst Salim Syed maintains Autolus Therapeutics (NASDAQ:AUTL) with a Outperform and lowers the price target from $12 to $10.

Benzinga Newsdesk

PRO
Needham Reiterates Buy on Autolus Therapeutics, Maintains $10 Price Target

Needham analyst Gil Blum reiterates Autolus Therapeutics (NASDAQ:AUTL) with a Buy and maintains $10 price target.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Initiates Coverage On Autolus Therapeutics with Buy Rating, Announces Price Target of $9

HC Wainwright & Co. analyst Emily Bodnar initiates coverage on Autolus Therapeutics (NASDAQ:AUTL) with a Buy rating and announces Price Target of $9.

Benzinga Newsdesk

Autolus Therapeutics PLC

Autolus Therapeutics Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
HC Wainwright & Co. Reiterates Buy on Autolus Therapeutics, Maintains $10 Price Target

PRO
HC Wainwright & Co. Maintains Buy on Autolus Therapeutics, Raises Price Target to $10

PRO
Needham Reiterates Buy on Autolus Therapeutics, Maintains $10 Price Target

PRO
Mizuho Maintains Outperform on Autolus Therapeutics, Lowers Price Target to $10

PRO
Needham Reiterates Buy on Autolus Therapeutics, Maintains $10 Price Target

PRO
HC Wainwright & Co. Initiates Coverage On Autolus Therapeutics with Buy Rating, Announces Price Target of $9

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

Autolus Therapeutics Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
HC Wainwright & Co. Reiterates Buy on Autolus Therapeutics, Maintains $10 Price Target

PRO
HC Wainwright & Co. Maintains Buy on Autolus Therapeutics, Raises Price Target to $10

PRO
Needham Reiterates Buy on Autolus Therapeutics, Maintains $10 Price Target

PRO
Mizuho Maintains Outperform on Autolus Therapeutics, Lowers Price Target to $10

PRO
Needham Reiterates Buy on Autolus Therapeutics, Maintains $10 Price Target

PRO
HC Wainwright & Co. Initiates Coverage On Autolus Therapeutics with Buy Rating, Announces Price Target of $9

People Also Watch

People Also Watch

Autolus Therapeutics PLC

Autolus Therapeutics Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROHC Wainwright & Co. Reiterates Buy on Autolus Therapeutics, Maintains $10 Price Target

PROHC Wainwright & Co. Maintains Buy on Autolus Therapeutics, Raises Price Target to $10

PRONeedham Reiterates Buy on Autolus Therapeutics, Maintains $10 Price Target

PROMizuho Maintains Outperform on Autolus Therapeutics, Lowers Price Target to $10

PRONeedham Reiterates Buy on Autolus Therapeutics, Maintains $10 Price Target

PROHC Wainwright & Co. Initiates Coverage On Autolus Therapeutics with Buy Rating, Announces Price Target of $9

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

Autolus Therapeutics Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROHC Wainwright & Co. Reiterates Buy on Autolus Therapeutics, Maintains $10 Price Target

PROHC Wainwright & Co. Maintains Buy on Autolus Therapeutics, Raises Price Target to $10

PRONeedham Reiterates Buy on Autolus Therapeutics, Maintains $10 Price Target

PROMizuho Maintains Outperform on Autolus Therapeutics, Lowers Price Target to $10

PRONeedham Reiterates Buy on Autolus Therapeutics, Maintains $10 Price Target

PROHC Wainwright & Co. Initiates Coverage On Autolus Therapeutics with Buy Rating, Announces Price Target of $9

People Also Watch

People Also Watch

PRO
HC Wainwright & Co. Reiterates Buy on Autolus Therapeutics, Maintains $10 Price Target

PRO
HC Wainwright & Co. Maintains Buy on Autolus Therapeutics, Raises Price Target to $10

PRO
Needham Reiterates Buy on Autolus Therapeutics, Maintains $10 Price Target

PRO
Mizuho Maintains Outperform on Autolus Therapeutics, Lowers Price Target to $10

PRO
Needham Reiterates Buy on Autolus Therapeutics, Maintains $10 Price Target

PRO
HC Wainwright & Co. Initiates Coverage On Autolus Therapeutics with Buy Rating, Announces Price Target of $9

PRO
HC Wainwright & Co. Reiterates Buy on Autolus Therapeutics, Maintains $10 Price Target

PRO
HC Wainwright & Co. Maintains Buy on Autolus Therapeutics, Raises Price Target to $10

PRO
Needham Reiterates Buy on Autolus Therapeutics, Maintains $10 Price Target

PRO
Mizuho Maintains Outperform on Autolus Therapeutics, Lowers Price Target to $10

PRO
Needham Reiterates Buy on Autolus Therapeutics, Maintains $10 Price Target

PRO
HC Wainwright & Co. Initiates Coverage On Autolus Therapeutics with Buy Rating, Announces Price Target of $9